After a drawn-out approval process, medical equipment company Baxter International received regulatory clearance for a new infusion pump machine that is expected to help the company capture more of ...

Errors in the setup or management of some of Baxter International’s infusion pumps could result in overlooked blockages in the pumps, potentially leading to serious injury or even death, the ...

For the third time in the last two years, Baxter has been hit with the FDA’s most serious label for a recall affecting its infusion pump systems. This time around, the Class I recall notice is linked ...

Furthers Baxter’s continued innovation in medication delivery and management Integrates Baxter’s decades of leadership in infusion therapy with innovative digital health solutions to build on the ...

Baxter International has launched the IV Verify Line Labeling System in the U.S. after debuting it at the 2026 American Organization for Nursing Leadership Conference, offering an automated way to ...

Baxter recalled over 277,000 infusion pumps due to the risk of the device failing to alarm users of repeated upstream occlusion events. The SIGMA Spectrum Infusion Pump with Master Drug Library ...

Data suggest machine learning and artificial intelligence could help hospitals align drug libraries more closely to clinical practices, which may advance infusion safety Study conducted in partnership ...

The FDA labeled 22,769 Baxter drug infusion devices as a Class I recall after receiving reports of false upstream occlusion alarms, which can delay therapy. The two infusion pumps, SIGMA Spectrum ...

Baxter International (NYSE:BAX) has issued an urgent medical device correction for software installed on certain Spectrum infusion pumps over concerns that they may be emitting false alarms that could ...

Baxter accused BD's Alaris infusion pumps of violating patent rights Judge rejects BD's request to rule for it before trial (Reuters) - Becton Dickinson & Co and its subsidiary CareFusion Corp must ...

NEW YORK (MarketWatch) -- Baxter Healthcare Corp. said Tuesday it plans to withdraw its 6060 Multi-Therapy Infusion Pump from the market over the next 12 months. The Deefield, Ill., company said the ...

LOS ANGELES (Reuters) - Baxter International Inc said on Monday it will recall its Colleague infusion pumps from the U.S. market on an order from the Food and Drug Administration under the company's ...